Nuo Therapeutics, Inc. (AURX) has 7 SEC Form 4 insider filings on record in the last 90 days. That includes 1 insider purchase totalling $10K. Most recent filing: Aug. 31, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| Aug. 31, 2026 filed Aug. 27, 2026 | JORDEN DAVID EMERSON CEO/CFO | +$9,539 | 8,773 | +0% | No | |
|
|
||||||
| Aug. 28, 2026 filed Aug. 27, 2026 | JORDEN DAVID EMERSON CEO/CFO | $9,539 | 8,773 | +0% | No | |
|
|
||||||
| July 2, 2026 filed June 29, 2026 | CLAUSEN PETER CSO/COO | $0 | 65,000 | 0% | No | |
|
|
||||||
| July 2, 2026 filed June 29, 2026 | JORDEN DAVID EMERSON CEO/CFO | — | +1,608 | — | No | |
|
|
||||||
| July 2, 2026 filed June 29, 2026 | Pittman Scott M. Director | — | +396 | — | No | |
|
|
||||||
Showing the 5 most recent of 7 filings in the last 90 days.
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free